| [1] |
Wilson B. Necrotizing fasciitis[J]. Am Surg, 1952, 18(4): 416-431.
|
| [2] |
Bonne SL, Kadri SS. Evaluation and Management of Necrotizing Soft Tissue Infections[J]. Infect Dis Clin North Am, 2017, 31(3): 497-511.
|
| [3] |
Harbrecht BG, Nash NA. Necrotizing Soft Tissue Infections: A Review[J]. Surg Infect (Larchmt), 2016, 17(5): 503-509.
|
| [4] |
Iacopi E, Coppelli A, Goretti C, et al. Necrotizing Fasciitis and The Diabetic Foot[J]. Int J Low Extrem Wounds, 2015, 14(4): 316-327.
|
| [5] |
Ahn J, Raspovic KM, Liu GT, et al. Lower Extremity Necrotizing Fasciitis in Diabetic and Nondiabetic Patients: Mortality and Amputation[J]. Int J Low Extrem Wounds, 2019, 18(2): 114-121.
|
| [6] |
Fernando SM, Tran A, Cheng W, et al. Necrotizing Soft Tissue Infection: Diagnostic Accuracy of Physical Examination, Imaging, and LRINEC Score: A Systematic Review and Meta-Analysis[J]. Ann Surg, 2019, 269(1): 58-65.
|
| [7] |
Khamnuan P, Chongruksut W, Jearwattanakanok K, et al. Necrotizing fasciitis: epidemiology and clinical predictors for amputation[J]. Int J Gen Med, 2015, 14(8): 195-202.
|
| [8] |
Goh T, Goh LG, Ang CH, et al. Early diagnosis of necrotizing fasciitis[J]. Br J Surg, 2014, 101(1): e119-125.
|
| [9] |
Zhang P, Lu J, Jing Y, et al. Global epidemiology of diabetic foot ulceration: a systematic review and meta-analysis (dagger)[J]. Ann Med, 2017, 49(2): 106-116.
|
| [10] |
Armstrong DG, Boulton AJM, Bus SA. Diabetic Foot Ulcers and Their Recurrence[J]. N Engl J Med, 2017, 376(24): 2367-2375.
|
| [11] |
Horn DL, Shen J, Roberts E, et al. Predictors of mortality, limb loss, and discharge disposition at admission among patients with necrotizing skin and soft tissue infections[J]. J Trauma Acute Care Surg, 2020, 89(1): 186-191.
|
| [12] |
Audureau E, Hua C, de Prost N, et al. Mortality of necrotizing fasciitis: relative influence of individual and hospital-level factors, a nationwide multilevel study, France, 2007-12[J]. Br J Dermatol, 2017, 177(6): 1575-1582.
|
| [13] |
Jabbour G, El-Menyar A, Peralta R, et al. Pattern and predictors of mortality in necrotizing fasciitis patients in a single tertiary hospital[J]. World J Emerg Surg, 2016, 11(40): 1-10.
|
| [14] |
Chen IW, Yang HM, Chiu CH, et al. Clinical Characteristics and Risk Factor Analysis for Lower-Extremity Amputations in Diabetic Patients With Foot Ulcer Complicated by Necrotizing Fasciitis[J]. Medicine (Baltimore), 2015, 94(44): e1957.
|
| [15] |
Volmer-Thole M, Lobmann R. Neuropathy and Diabetic Foot Syndrome[J]. Int J Mol Sci, 2016, 17(6): 917.
|
| [16] |
Bandyk DF. The diabetic foot: Pathophysiology, evaluation, and treatment[J]. Semin Vasc Surg, 2018, 31(2/4): 43-48.
|
| [17] |
Sage RA, Webster JK, Fisher SG. Outpatient care and morbidity reduction in diabetic foot ulcers associated with chronic pressure callus[J]. J Am Podiatr Med Assoc, 2001, 91(6): 275-279.
|
| [18] |
Markakis K, Bowling FL, Boulton AJ. The diabetic foot in 2015: an overview[J]. Diabetes Metab Res Rev, 2016, 32 (Suppl 1): 169-178.
|
| [19] |
Arosi I, Hiner G, Rajbhandari S. Pathogenesis and Treatment of Callus in the Diabetic Foot[J]. Curr Diabetes Rev, 2016, 12(3): 179-183.
|
| [20] |
Schreml S, Szeimies RM, Prantl L, et al. Oxygen in acute and chronic wound healing[J]. Br J Dermatol, 2010, 163(2): 257-268.
|
| [21] |
Catrina SB, Zheng X. Disturbed hypoxic responses as a pathogenic mechanism of diabetic foot ulcers[J]. Diabetes Metab Res Rev, 2016, 32 (Suppl 1): 179-185.
|
| [22] |
Hoenig MR, Bianchi C, Sellke FW. Hypoxia inducible factor-1 alpha, endothelial progenitor cells, monocytes, cardiovascular risk, wound healing, cobalt and hydralazine: a unifying hypothesis[J]. Curr Drug Targets, 2008, 9(5): 422-435.
|
| [23] |
Wang H, Feng Y, Jin X, et al. Augmentation of hypoxia-inducible factor-1-alpha in reinfused blood cells enhances diabetic ischemic wound closure in mice[J]. Oncotarget, 2017, 8(69): 114251-114258.
|
| [24] |
Krishnaswamy VR, Mintz D, Sagi I. Matrix metalloproteinases: The sculptors of chronic cutaneous wounds[J]. Biochim Biophys Acta Mol Cell Res, 2017, 1864(11 Pt B): 2220-2227.
|
| [25] |
Davis FM, Kimball A, Boniakowski A, et al. Dysfunctional Wound Healing in Diabetic Foot Ulcers: New Crossroads[J]. Curr Diab Rep, 2018, 18(1): 2.
|
| [26] |
Dunnill C, Patton T, Brennan J, et al. Reactive oxygen species (ROS) and wound healing: the functional role of ROS and emerging ROS-modulating technologies for augmentation of the healing process[J]. Int Wound J, 2017, 14(1): 89-96.
|
| [27] |
Morgan MS. Diagnosis and management of necrotising fasciitis: a multiparametric approach[J]. J Hosp Infect, 2010, 75(4): 249-257.
|
| [28] |
Grigoropoulou P, Eleftheriadou I, Jude EB, et al. Diabetic Foot Infections: an Update in Diagnosis and Management[J]. Curr Diab Rep, 2017, 17(1): 3.
|
| [29] |
李艳艳，刚晓坤，肖显超，等. 糖尿病足合并感染的病原菌分布特点及药敏变迁的临床观察[J]. 中国糖尿病杂志，2019, 27(1): 16-21.
|
| [30] |
Eleftheriadou I, Tentolouris N, Argiana V, et al. Methicillin-resistant Staphylococcus aureus in diabetic foot infections[J]. Drugs, 2010, 70(14): 1785-1797.
|
| [31] |
Kwon KT, Armstrong DG. Microbiology and Antimicrobial Therapy for Diabetic Foot Infections[J]. Infect Chemother, 2018, 50(1): 11-20.
|
| [32] |
Clinton A, Carter T. Chronic Wound Biofilms: Pathogenesis and Potential Therapies[J]. Lab Med, 2015, 46(4): 277-284.
|
| [33] |
Gompelman M, van Asten SA, Peters EJ. Update on the Role of Infection and Biofilms in Wound Healing: Pathophysiology and Treatment[J]. Plast Reconstr Surg, 2016, 138(3 Suppl): 61S-70S.
|
| [34] |
Mottola C, Mendes JJ, Cristino JM, et al. Polymicrobial biofilms by diabetic foot clinical isolates[J]. Folia Microbiol (Praha), 2016, 61(1): 35-43.
|
| [35] |
Banu A, Noorul Hassan MM, Rajkumar J, et al. Spectrum of bacteria associated with diabetic foot ulcer and biofilm formation: A prospective study[J]. Australas Med J, 2015, 8(9): 280-285.
|
| [36] |
Scherr TD, Hanke ML, Huang O, et al. Staphylococcus aureus Biofilms Induce Macrophage Dysfunction Through Leukocidin AB and Alpha-Toxin[J]. mBio, 2015, 6(4): e01021-15.
|
| [37] |
Ramirez T, Shrestha A, Kishen A. Inflammatory potential of monospecies biofilm matrix components[J]. Int Endod J, 2019, 52(7): 1020-1027.
|
| [38] |
Ghotaslou R, Memar MY, Alizadeh N. Classification, microbiology and treatment of diabetic foot infections[J]. J Wound Care, 2018, 27(7): 434-441.
|
| [39] |
Tessier JM, Sanders J, Sartelli M, et al. Necrotizing Soft Tissue Infections: A Focused Review of Pathophysiology, Diagnosis, Operative Management, Antimicrobial Therapy, and Pediatrics[J]. Surg Infect (Larchmt), 2020, 21(2): 81-93.
|
| [40] |
Wynn M, Freeman S. The efficacy of negative pressure wound therapy for diabetic foot ulcers: A systematised review[J]. J Tissue Viability, 2019, 28(3): 152-160.
|